Singapore-listed utility company Sembcorp Industries on Sunday said it will acquire clean energy platform Vector Green Energy for ₹2,780 crore to expand its renewable energy footprint in India to 3 gigawatts (GW).

Vector Green Energy, owned by funds managed by the Indian subsidiary of Global Infrastructure Partners, has 519 megawatts of operational (495 MW solar and 24 MW wind) and 64 MW of solar projects under development. The firm reportedly also has 1 GW of investment-ready assets in the pipeline.

The completion of the acquisition in the next three months will bring the Singapore-based group’s gross renewable energy capacity to 8.5 GW, closer to its 2025 target of 10 GW of gross installed renewable capacity, Sembcorp said in a statement.

The acquisition complements Sembcorp’s existing portfolio which comprises 90 per cent of wind energy projects. A solar heavy portfolio of Vector Green Energy will balance it and increase Sembcorp’s spread from 7 states in India to 13 States.

Also, with as much as 90 per cent of operational capacity, Vector Green Energy provides a portfolio that will contribute to cash flows immediately.

Related Stories

Manipal Healthcare to build ₹400-crore multi-specialty facility in Raipur

The new hospital is expected to be operational in two years and it would add 300 beds to the existing bed capacity

Vector Green Energy has a 19-year weighted average remaining life of pacts to sell power. It has signed power purchase agreements for all but 24 MW or 4 per cent of the portfolio.

Vipul Tuli, CEO of South Asia, Sembcorp Industries, said: “This acquisition brings the significant utility-scale solar capacity to our India business, which will complement our existing wind portfolio. It also broadens and deepens our renewable energy capabilities and presence across states in India, and positions us well for further green growth in the country”.

With this acquisition, Sembcorp will now have a portfolio of 8.7 GW, comprising 6.7 GW operational and the rest under development.

Tuli said, including Vector Green, Sembcorp’s gross renewables portfolio installed and under development in India will total 3 GW, comprising 1 GW of solar assets and 2GW of wind assets.

“Sembcorp Industries (Sembcorp) announces that its wholly-owned subsidiary, Sembcorp Green Infra Limited, has signed an agreement with India Infrastructure Fund II, a fund managed by Global Infrastructure Partners India Pvt Ltd, to acquire 100 per cent interest in Vector Green Energy Private Limited (Vector Green) for a base equity consideration of approximately ₹2,780 crore,” it said in the statement.

The acquisition will be funded through internal cash resources and external borrowings.

The completion of the acquisition is subject to customary closing conditions and is expected by the first quarter of 2023.

Related Stories

Paris Agreement requires phase down of all fossil fuels: India at COP27

Indian negotiators cited the sixth assessment report of the IPCC

Besides Sembcorp, electricity producer Torrent Power Ltd too was interested in Vector Green Energy. But, the Singapore utility won the race.

India is seeing a spurt in investments in the renewable sector as it targets to cut 1 billion tonnes of carbon emissions by the end of this decade and reach net-zero by 2070.

Prime Minister Narendra Modi’s government has also pledged to cut emissions by 45 per cent from 2005 levels and use non-fossil fuel sources to power half its installed generation capacity by 2030.

Wong Kim Yin, Group President & CEO, Sembcorp Industries, said: “Sembcorp remains committed to growing its renewables portfolio in India, one of the fastest growing renewables markets in the world. This acquisition is aligned with the Group’s brown-to-green transformation strategy. With the completion of this acquisition, Sembcorp’s gross renewable energy capacity will increase to 8.5 GW, pushing us closer towards our 2025 target of 10 GW”.

SHARE

• Copy link
• Email
• Facebook
• Twitter
• Telegram
• LinkedIn
• WhatsApp
• Reddit

Published on November 13, 2022

el.parentNode == parent) if (filtered_divs[1]) { var newElement = document.createElement(‘div’); newElement.id = slotName; newElement.setAttribute(“class”, “dfp-ad element no-border hide-system”); filtered_divs[1].parentNode.insertBefore(newElement, filtered_divs[1].nextSibling) } } catch (err) { console.log(“ad error”) }googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-1660731707267-0’); }); }}); ]]>

el.parentNode == parent) if (filtered_divs[4]) { var newElement = document.createElement(‘div’); newElement.id = slotName; newElement.setAttribute(“class”, “dfp-ad element bill-board-ad no-border py-2 mb-3 hide-mobile text-center”); filtered_divs[4].parentNode.insertBefore(newElement, filtered_divs[4].nextSibling) } } catch (err) { console.log(“ad error”) }googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-1660731171391-0’); }); }}); ]]>

el.parentNode == parent) if (filtered_divs[4]) { var newElement = document.createElement(‘div’); newElement.id = slotName; newElement.setAttribute(“class”, “dfp-ad element no-border hide-system text-center”); filtered_divs[4].parentNode.insertBefore(newElement, filtered_divs[4].nextSibling) } } catch (err) { console.log(“ad error”) }googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-1660731946557-0’); }); }}); ]]>

Malaysia’s IHH Healthcare has stressed that it is committed to the Indian market on a long-term basis and Fortis Healthcare remains its main platform for growth in the country.

Terming the freeze on its open offer to acquire an additional 26.1 per cent stake in Fortis as ‘unfortunate’, the Malaysian entity feels that the ongoing legal battle has prevented it so far from injecting additional capital into the Indian healthcare provider. The company, which acquired a 31.17 per cent stake in Fortis by infusing fresh capital of ₹4,000 crore in November 2018, is currently waiting for a go-ahead from capital markets regulator, Sebi to proceed with its stalled open offer to acquire additional 26.1 per cent stake in the domestic healthcare major.

The open offer, which was originally scheduled to commence on December 18, 2018 and close on January 1, 2019, entailing a total sum of ₹3,300 crore, could not materialise due to a Supreme Court order.

Related Stories

Supreme Court orders forensic audit on Fortis-IHH share sale

The apex court also refused to allow the open offer from Malaysia’s IHH Healthcare Bhd to proceed

IHH Healthcare Managing Director and CEO, Kelvin Loh said the last four years have turned out to be very frustrating for the company that counts India as one of its key markets.

“Is there frustration? Yes there is,” he said when asked about the legal proceedings which began in 2018.

“We feel that we are the aggrieved party here because the Supreme Court case was really between Daichii Sankyo and Singh brothers, in which we really had no part,” he noted.

Loh noted that IHH counts India, Turkiye, Malaysia, and Singapore as its major markets even as it operates 82 hospitals across ten nations. “When we say we are committed to healthcare in India, we see a lot of opportunity for growth. We will be here for the long term because we are not financial investors, we are a strategic healthcare operator and the main platform for growth in India for us is Fortis,” Loh said.

The battle so far

The IHH-Fortis deal got stuck due to a legal battle between Daiichi and the former promoters of Fortis Healthcare.

The former promoters of Fortis Healthcare —  Malvinder Singh and Shivinder Singh — were facing the court battle after Japanese firm, Daiichi Sankyo challenged the Fortis-IHH share deal to recover the ₹3,600-crore arbitration award that it had won before a Singapore tribunal against the Singh brothers.

Related Stories

Old ghosts continue to haunt the IHH-Fortis transaction

Experts concerned on the impact it would have on investment in healthcare

In 2018, when some Indian lenders sold the pledged shares of Fortis Healthcare to the Malaysia-based firm, Daiichi went to court alleging that the former promoters of Fortis had assured them that their shares in the Indian hospital chain will cover the arbitral award amount.

Later, the Supreme Court ordered status quo with regard to the sale of controlling stakes of Fortis Healthcare to IHH Healthcare by Malvinder Singh and Shivinder Singh, and put on hold IHH’s open offer for an additional 26.1 per cent stake in Fortis.

The 26.1 per cent stake would have increased IHH’s shareholding in Fortis to 57 per cent.

“But unfortunately, it got stuck. Even more unfortunate has been the suspension of the process for four years now and that really frustrates us,” Loh noted.

IHH has already brought in management and operational changes in Fortis helping the company, which was on the verge of bankruptcy, recover financially.

IHH, however, aspires to help Fortis grow even faster, Loh said.

Related Stories

Manipal Healthcare to build ₹400-crore multi-specialty facility in Raipur

The new hospital is expected to be operational in two years and it would add 300 beds to the existing bed capacity

Commitment to Fortis

“We are committed to Fortis, we are committed to healthcare in India. We keep transforming and improving the healthcare product that we provide here in the country and of course, we aspire that we can grow even faster. Maybe inject more capital to grow on this,” he noted.

Fortis through its own means can grow from its current 4,000 beds capacity to 5,000 beds in the next two years, Loh said.

“With our support, it can grow even faster. If we can bring in additional capital for growth, greenfield expansion or even acquisitions, it can grow even more. We would like to do that,” he noted.

Fortis Healthcare Chairman, Ravi Rajagopal said it was unfortunate the way things have turned out for IHH Healthcare.

“In its ruling (the Supreme Court), according to my mind, has not cast a single negative aspersion either on IHH or Fortis. Despite that, the fact that it has taken so long, the frustration for Fortis is that it has been bereft of capital to grow its business,” he said.

Related Stories

Healthcare firm Even raises $15 million funding

Receives funding from Alpha Wave and Aspada (Lightrock)

IHH stake consolidation would have resulted in capital infusion in Fortis helping it scale up operations.

Rajagopal said that the majority of the initial ₹4,000 crore capital infusion by IHH went into the buyback of assets and debt payoff, leaving Fortis with little funds for expanding operations.

“If we want to grow in the way the rest of our peer group has grown, through both internal investments as well as inorganic, then we would need that extra capital. As a major shareholder, we look at IHH to help us secure that capital. Till such time, till September (this year), while the status quo was in force, those possibilities could not have been explored, but now those options are open,” he said.

In a statement last week, IHH Healthcare noted that following the recent judgment of the Supreme Court of India, the special leave petition, the original contempt petition and the suo moto contempt petition are disposed of.

“The honourable Supreme Court has not found nor indicated any wrongdoing by IHH in terms of our investment into Fortis in its final written judgment dated September 22, 2022. There is also currently no court order pending against IHH in these proceedings,” it said.

Accordingly, IHH is now in discussion with Sebi to determine the next steps pertaining to the mandatory tender offer in Fortis, in full compliance with all requisite regulations, the Malaysian firm said.

On replacing Fortis brand name with Parkway, Rajagopal said: “The Fortis board had decided a year ago to change the brand name to Parkway because the Fortis brand does not belong to Fortis Ltd, it belongs to a company, which was owned and controlled by the former Fortis promoters.” He further said: “We filed a notice with the stock exchange as well as with the Supreme Court last year on our intent. Now with the Supreme Court order behind us, we will be moving very quickly to change the brand name.” When asked for the timeframe for the same, Rajagopal said the matter involves trademark registration.

“We already have checked out the trademarks, but there is a process of filing it formally and going through that due process. It should take a few months,” he added.

IHH had pipped rival Manipal-TPG combine in the race to acquire Fortis Healthcare.

SHARE

• Copy link
• Email
• Facebook
• Twitter
• Telegram
• LinkedIn
• WhatsApp
• Reddit

Published on November 13, 2022

Astral Limited on Friday posted a standalone net profit of ₹65 crore for the quarter that ended September 30, 2022, down 51 per cent from ₹134 crore in the corresponding quarter last year.

Standalone revenues from operations stood at ₹1,042 crore for the quarter, down by 7 per cent from ₹1,116 crore in the same quarter last year.

On a consolidated basis, the company recorded a net profit of ₹75 crore, down 48 per cent from ₹143 crore in the same quarter last year. Consolidated revenues from operations stood at ₹1,172 crore, down 2.4 per cent from ₹1,200 crore in the same quarter last year.

Company’s consolidated EBIDTA fell by 28 per cent to ₹157 crore as against ₹219 crore in the corresponding quarter a year ago.

Margin pressure was seen during the quarter mainly because of a reduction in key polymer (PVC) prices to the tune of ₹30 per kg which resulted in the inventory loss of about ₹45 crore in the second quarter and ₹25 crore in the first quarter.

“However, due to a better value-added products mix and higher CPVC contribution, we were still in double-digit EBDITA margins in the plumbing segment,” the company said.

Other pressure

Adhesive margins were also under pressure due to higher prices of key raw materials during the second quarter but now pressure on raw materials has started coming down which will help in partial improvement in margin in the third quarter and will give full benefit in the fourth quarter.

“Due to volatility in foreign currency, during the half year ended September 30, 2022, we have incurred a loss of ₹24 crore on account of foreign exchange fluctuation, out of which ₹15 crore is unrealised, we may get a reversal of such unrealised loss, if rupee will appreciate,” the company said.

Astral Limited shares ended flat at ₹2,062.95 on BSE Friday.

SHARE

• Copy link
• Email
• Facebook
• Twitter
• Telegram
• LinkedIn
• WhatsApp
• Reddit

Published on November 13, 2022

el.parentNode == parent) if (filtered_divs[1]) { var newElement = document.createElement(‘div’); newElement.id = slotName; newElement.setAttribute(“class”, “dfp-ad element no-border hide-system”); filtered_divs[1].parentNode.insertBefore(newElement, filtered_divs[1].nextSibling) } } catch (err) { console.log(“ad error”) }googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-1660731707267-0’); }); }}); ]]>

el.parentNode == parent) if (filtered_divs[4]) { var newElement = document.createElement(‘div’); newElement.id = slotName; newElement.setAttribute(“class”, “dfp-ad element bill-board-ad no-border py-2 mb-3 hide-mobile text-center”); filtered_divs[4].parentNode.insertBefore(newElement, filtered_divs[4].nextSibling) } } catch (err) { console.log(“ad error”) }googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-1660731171391-0’); }); }}); ]]>

el.parentNode == parent) if (filtered_divs[4]) { var newElement = document.createElement(‘div’); newElement.id = slotName; newElement.setAttribute(“class”, “dfp-ad element no-border hide-system text-center”); filtered_divs[4].parentNode.insertBefore(newElement, filtered_divs[4].nextSibling) } } catch (err) { console.log(“ad error”) }googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-1660731946557-0’); }); }}); ]]>